Pharma Pulse 1/21/25: Reaching Diverse Patient Populations With Personalized Treatment Methods, Managing Cancer Treatment Amid a Nationwide IV Fluid Shortage & more

Reaching Diverse Patient Populations With Personalized Treatment Methods

Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.

Managing Cancer Treatment Amid a Nationwide IV Fluid Shortage

The closure of Baxter’s North Cove facility has significantly impacted existing IV fluid shortages into 2025.

FTC Says Consumer Data Is Behind ‘Surveillance’ Pricing

Retailers can tailor prices based on customer data including location, demographics or shopping history, the US Federal Trade Commission said in initial study findings, raising concerns about the use of what they termed “surveillance pricing.”

Antibody Drug Conjugates Market Report 2025-2035: ADCs - Pioneering the Future of Precision Cancer Therapy

The "Antibody Drug Conjugates Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. World revenue for the Antibody Drug Conjugates Market is set to surpass US$16 billion in 2025, with strong revenue growth through to 2035.
Subin Baral on LinkedIn

Thank you for the opportunity to speak with Pharmaceutical Executive and sharing EY perspectives. Explore Full EY M&A report 2025 report at https://lnkd.in/eR3j___k

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs